Home / Resource Library / Assessment of CD20 Marker as a Prognostic Predictor for Patients with Classical Hodgkin LymphomaAssessment of CD20 Marker as a Prognostic Predictor for Patients with Classical Hodgkin Lymphoma Study examined CD20 as a biomarker in Hodgkin lymphoma.